Molekulare Stratifizierung von kolorektalen Karzinomen – was hat Relevanz für die klinische Praxis?

J.H.L. Neumann, A. Jung, T. Kirchner, Molekulare Pathologie des kolorektalen Karzinoms Pathologe. ,vol. 36, pp. 137- 144 ,(2015) , 10.1007/S00292-015-0005-3

C. Cremolini, M. Di Bartolomeo, A. Amatu, C. Antoniotti, R. Moretto, R. Berenato, F. Perrone, E. Tamborini, G. Aprile, S. Lonardi, A. Sartore-Bianchi, G. Fontanini, M. Milione, C. Lauricella, S. Siena, A. Falcone, F. de Braud, F. Loupakis, F. Pietrantonio, BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis Annals of Oncology. ,vol. 26, pp. 2092- 2097 ,(2015) , 10.1093/ANNONC/MDV290

Feriyl Bhaijee, Thomas Huebner, Ralph H. Hruban, Laura D. Wood, Nathan Cuka, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, Shibin Zhou, Toby C. Cornish, Janis M. Taube, Robert A. Anders, James R. Eshleman, Bert Vogelstein, Luis A. Diaz, Dung T. Le, Jennifer N. Uram, Hao Wang, Bjarne R. Bartlett, Holly Kemberling, Aleksandra D. Eyring, Andrew D. Skora, Brandon S. Luber, Nilofer S. Azad, Dan Laheru, Barbara Biedrzycki, Ross C. Donehower, Atif Zaheer, George A. Fisher, Todd S. Crocenzi, James J. Lee, Steven M. Duffy, Richard M. Goldberg, Albert de la Chapelle, Minori Koshiji, PD-1 Blockade in Tumors with Mismatch-Repair Deficiency The New England Journal of Medicine. ,vol. 372, pp. 2509- 2520 ,(2015) , 10.1056/NEJMOA1500596

Y. Nancy You, Rudolph B. Rustin, James D. Sullivan, Oncotype DX(®) colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: A review of the evidence. Surgical Oncology-oxford. ,vol. 24, pp. 61- 66 ,(2015) , 10.1016/J.SURONC.2015.02.001

Chiara Cremolini, Fotios Loupakis, Carlotta Antoniotti, Cristiana Lupi, Elisa Sensi, Sara Lonardi, Silvia Mezi, Gianluca Tomasello, Monica Ronzoni, Alberto Zaniboni, Giuseppe Tonini, Chiara Carlomagno, Giacomo Allegrini, Silvana Chiara, Mauro D'Amico, Cristina Granetto, Marina Cazzaniga, Luca Boni, Gabriella Fontanini, Alfredo Falcone, FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study The Lancet Oncology. ,vol. 16, pp. 1306- 1315 ,(2015) , 10.1016/S1470-2045(15)00122-9

Xiaoyun Liao, Paul Lochhead, Reiko Nishihara, Teppei Morikawa, Aya Kuchiba, Mai Yamauchi, Yu Imamura, Zhi Rong Qian, Yoshifumi Baba, Kaori Shima, Ruifang Sun, Katsuhiko Nosho, Jeffrey A. Meyerhardt, Edward Giovannucci, Charles S. Fuchs, Andrew T. Chan, Shuji Ogino, Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. The New England Journal of Medicine. ,vol. 367, pp. 1596- 1606 ,(2012) , 10.1056/NEJMOA1207756

Daniel J. Sargent, Silvia Marsoni, Genevieve Monges, Stephen N. Thibodeau, Roberto Labianca, Stanley R. Hamilton, Amy J. French, Brian Kabat, Nathan R. Foster, Valter Torri, Christine Ribic, Axel Grothey, Malcolm Moore, Alberto Zaniboni, Jean-Francois Seitz, Frank Sinicrope, Steven Gallinger, Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer Journal of Clinical Oncology. ,vol. 28, pp. 3219- 3226 ,(2010) , 10.1200/JCO.2009.27.1825

Piero Dalerba, Debashis Sahoo, Soonmyung Paik, Xiangqian Guo, Greg Yothers, Nan Song, Nate Wilcox-Fogel, Erna Forgó, Pradeep S Rajendran, Stephen P Miranda, Shigeo Hisamori, Jacqueline Hutchison, Tomer Kalisky, Dalong Qian, Norman Wolmark, George A Fisher, Matt van de Rijn, Michael F Clarke, None, CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer The New England Journal of Medicine. ,vol. 374, pp. 211- 222 ,(2016) , 10.1056/NEJMOA1506597

Fred T. Bosman, Pu Yan, Molecular pathology of colorectal cancer. Polish Journal of Pathology. ,vol. 65, pp. 257- 266 ,(2014) , 10.5114/PJP.2014.48094

Eric Van Cutsem, Andrés Cervantes, Rene Adam, Alberto Sobrero, JH Van Krieken, D Aderka, E Aranda Aguilar, Alberto Bardelli, A Benson, G Bodoky, Fortunato Ciardiello, André D'Hoore, E Diaz-Rubio, J-Y Douillard, M Ducreux, Alfredo Falcone, A Grothey, T Gruenberger, Karin Haustermans, V Heinemann, P Hoff, C-H Köhne, R Labianca, P Laurent-Puig, B Ma, T Maughan, K Muro, N Normanno, P Österlund, WJG Oyen, D Papamichael, G Pentheroudakis, P Pfeiffer, TJ Price, C Punt, J Ricke, A Roth, R Salazar, W Scheithauer, HJ Schmoll, J Tabernero, J Taïeb, Sabine Tejpar, H Wasan, T Yoshino, A Zaanan, D Arnold, None, ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Annals of Oncology. ,vol. 27, pp. 1386- 1422 ,(2016) , 10.1093/ANNONC/MDW235